Bio Protocol
BIO
Evaluation Score
Overall rating on a scale of 0-10
Dimension Breakdown
AI Analysis
Comprehensive evaluation of the token
BIO (Bio Protocol) functions as a decentralized science (DeSci) launchpad and meta-governance protocol governing BioDAOs across Ethereum, Base, Solana, and BSC. The project demonstrates solid development activity (7.5/10), evidenced by upgrades including Bio V1, Bio V2 with BioXP staking, and recent releases like the OpenLabs AI Research Hub in mid-2026. The founding team is experienced and public, with backgrounds spanning Molecule and VitaDAO (6.5/10), supported by active market liquidity and Binance Launchpool backing (6.0/10). Community engagement remains active, though largely driven by token incentives (6.0/10). On the downside, tokenomics are constrained by an uncapped maximum supply subject to governance-controlled inflation (5.5/10). Security scored 4.5/10 primarily due to an unverified third-party audit trail and a severe drawdown from its all-time high; however, no exploits, hacks, delistings, or regulatory actions were identified, meaning no overall red-flag cap applies. Across all six evaluated sections, the weighted average yields an overall score of 6.1/10.
Development Activity
Code updates and developer engagement
Community Support
Social media presence and community engagement
Tokenomics
Supply, distribution, and utility
Market & Use Case
Value proposition and competitive landscape
Team & Governance
Team background and project governance
Security & Audits
Security history and audit status
About Bio Protocol (BIO)
Bio Protocol (BIO) is a decentralized science (DeSci) protocol and launchpad designed to facilitate the funding, coordination, and creation of specialized BioDAOs and tokenized scientific research. Operating across Ethereum, Base, Solana, and BSC, the protocol serves as an infrastructure layer for biotech research initiatives, governed under the Bio.xyz Association. The project was founded by a public team including Paul Kohlhaas, Clemens Ortlepp, James Sinka, and Tyler Golato, drawing on their experience from earlier DeSci initiatives such as Molecule and VitaDAO.
The BIO token functions as a meta-governance and utility asset, allowing holders to participate in protocol governance via Snapshot and veBIO staking mechanisms. The token provides governance exposure to a portfolio of underlying BioDAO tokens and protocol-owned liquidity yields. The starting and total supply is 3,320,000,000 BIO with an uncapped maximum supply that permits governance-controlled minting and inflation. Project milestones have included the Bio V1 rollout, the Bio V2 upgrade featuring the BioXP staking system, and research platform deployments such as the OpenLabs hub.
From a market and security perspective, Bio Protocol has experienced a significant price drawdown of approximately 96% to 97% from its all-time high of roughly $0.92. Additional structural risks identified in evaluations include an unverified third-party audit history, discretionary inflation through an unbounded maximum token supply, and governance centralization around the founding team during its initial phases, although no protocol hacks, exploits, or regulatory actions have been documented.